These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37914282)

  • 1. Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients　- A Report From the West Tokyo Heart Failure Registry.
    Ohata T; Niimi N; Shiraishi Y; Nakatsu F; Umemura I; Kohno T; Nagatomo Y; Takei M; Ono T; Sakamoto M; Nakano S; Fukuda K; Kohsaka S; Yoshikawa T
    Circ J; 2023 Dec; 88(1):22-30. PubMed ID: 37914282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry.
    Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G
    Eur J Heart Fail; 2023 Jul; 25(7):1132-1144. PubMed ID: 37317585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
    Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure.
    Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G
    J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
    Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
    Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of heart failure guideline-directed medication during hospitalization: prevalence, risk factors, and outcomes.
    Palin V; Drozd M; Garland E; Malik A; Straw S; McGinlay M; Simms A; Gatenby VK; Sengupta A; Levelt E; Witte KK; Kearney MT; Cubbon RM
    ESC Heart Fail; 2022 Oct; 9(5):3298-3307. PubMed ID: 35796239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand.
    Teng TK; Tay WT; Ouwerkerk W; Tromp J; Richards AM; Gamble G; Greene SJ; Yiu KH; Poppe K; Ling LH; Lund M; Sim D; Devlin G; Loh SY; Troughton R; Ren QW; Jaufeerally F; Lee SGS; Tan RS; Soon DKN; Leong G; Ong HY; Yeo DPS; Lam CSP; Doughty RN
    ESC Heart Fail; 2023 Apr; 10(2):1280-1293. PubMed ID: 36722315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
    Sumarsono A; Xie L; Keshvani N; Zhang C; Patel L; Alonso WW; Thibodeau JT; Fonarow GC; Van Spall HGC; Messiah SE; Pandey A
    Circulation; 2024 Feb; 149(7):510-520. PubMed ID: 38258605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.
    Cox ZL; Zalawadiya SK; Simonato M; Redfors B; Zhou Z; Kotinkaduwa L; Zile MR; Udelson JE; Lim DS; Grayburn PA; Mack MJ; Abraham WT; Stone GW; Lindenfeld J
    JACC Heart Fail; 2023 Jul; 11(7):791-805. PubMed ID: 37115135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
    Matsushita K; Delmas C; Marchandot B; Roubille F; Lamblin N; Leurent G; Levy B; Elbaz M; Champion S; Lim P; Schneider F; Khachab H; Carmona A; Trimaille A; Bourenne J; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Biendel C; Labbe V; Combaret N; Mansourati J; Filippi E; Maizel J; Merdji H; Lattuca B; Gerbaud E; Bonnefoy E; Puymirat E; Bonello L; Morel O
    J Am Heart Assoc; 2024 Mar; 13(5):e030975. PubMed ID: 38390813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy.
    Malgie J; Clephas PRD; Brunner-La Rocca HP; de Boer RA; Brugts JJ
    Heart Fail Rev; 2023 Sep; 28(5):1221-1234. PubMed ID: 37311917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry.
    Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH
    J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
    Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.
    Cotter G; Deniau B; Davison B; Edwards C; Adamo M; Arrigo M; Barros M; Biegus J; Celutkiene J; Cerlinskaite-Bajore K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pang PS; Pagnesi M; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Tomasoni D; Voors A; Mebazaa A
    JAMA Cardiol; 2024 Feb; 9(2):114-124. PubMed ID: 38150260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient-Pooled Analysis From the Kor HF and Kor AHF Registries.
    Choi KH; Choi JO; Jeon ES; Lee GY; Choi DJ; Lee HY; Kim JJ; Chae SC; Baek SH; Kang SM; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
    J Am Heart Assoc; 2018 Nov; 7(21):e009806. PubMed ID: 30608208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
    Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
    ESC Heart Fail; 2023 Feb; 10(1):223-233. PubMed ID: 36193578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction.
    Patel J; Rassekh N; Fonarow GC; Deedwania P; Sheikh FH; Ahmed A; Lam PH
    Drugs; 2023 Jun; 83(9):747-759. PubMed ID: 37254024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.